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Abstract
Anthocyanins are natural colorant belonging to the Xavonoid family, widely distributed among Xowers, fruits, and vegetables. Some
Xavonoids have been found to possess anticarcinogenic, cytotoxic, cytostatic, antioxidant, and anti-inXammatory properties. Since
increased nitric oxide (NO) plays a role in inXammation, we have investigated whether the pharmacological activity of the anthocyanin
fraction of a blackberry extract (cyanidin-3-O-glucoside representing about 88% of the total anthocyanin content) was due to the sup-
pression of NO synthesis. The markedly increased production of nitrites by stimulation of J774 cells with lipopolysaccharide (LPS) for
24 h was concentration-dependently inhibited by the anthocyanin fraction (11, 22, 45, and 90 g/ml) of the extract. Moreover, this inhibi-
tion was dependent on a dual mechanism, since the extract attenuated iNOS protein expression and decreased the iNOS activity in lungs
from LPS-stimulated rats. Inhibition of iNOS protein expression appeared to be at the transcriptional level, since the extract and similarly
cyanidin-3-O-glucoside (10, 20, 40, and 80 g/ml, amounts corresponding to the concentrations present in the extract) decreased LPS-
induced NF-B activation, through inhibition of IB degradation, and reduced ERK-1/2 phosphorylation in a concentration-dependent
manner. In conclusion, our study demonstrates that at least some part of the anti-inXammatory activity of blackberry extract is due to the
suppression of NO production by cyanidin-3-O-glucoside, which is the main anthocyanin present in the extract. The mechanism of this
inhibition seems to be due to an action on the expression/activity of the enzyme. In particular, the protein expression was inhibited
through the attenuation of NF-B and/or MAPK activation.
© 2005 Elsevier Inc. All rights reserved.
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oxy derivatives of Xavilium salts, are natural colorant
belonging to the Xavonoid family. They are widely distrib-
uted among Xowers, fruits, and vegetables. Epidemiological
studies have shown that the consumption of vegetables,
fruits, and tea is associated with a decreased risk of cancer
and Xavonoids are believed to play an important role in
delaying or preventing carcinogenesis [1–4]. Some Xavo-
noids have been found to possess anticarcinogenic [4,5],
anti-inXammatory [6], antiviral [7], cytotoxic [8], cytostatic
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doi:10.1016/j.niox.2005.10.003[9], and antioxidant [10] properties. For example, cyanidin-
3-O-glucoside exhibits free radical scavenging activity [11],
protects against endothelial dysfunction [12], and decreases
myocardium damage [13]. Thus, a plant-derived diet might
contain certain Xavonoids that exert these healthy eVects,
thereby protecting from some diseases.
Nitric oxide (NO) is known to participate in the physi-
ological and pathological functions of many organs [14],
in fact it plays a major role in regulating vascular tone,
neurotransmission, killing of microorganisms and
tumour cells, and other homeostatic mechanisms [15].
High levels of NO have been described in a variety of
pathophysiological processes including various forms of
circulatory shock [16], inXammation [17], and carcino-
C. Pergola et al. / Nitric Oxide 15 (2006) 30–39 31genesis [18]. NO is synthesized by nitric oxide synthases
(NOS) [14]. To date, three NOS isoforms have been iden-
tiWed: neuronal NOS (nNOS or NOS I), inducible NOS
(iNOS or NOS II), and endothelial NOS (eNOS or NOS
III) [19]. The nNOS and eNOS isoforms are constitu-
tively expressed in neuronal and endothelial cells, respec-
tively, and are Ca2+/calmodulin-dependent. The iNOS
isoform is not constitutively present, it can be rapidly
induced by inXammatory stimuli, including toxins such
as lipopolysaccharide (LPS) and cytokines, and its acti-
vation is Ca2+/calmodulin-independent [20]. NO produc-
tion by iNOS is mainly regulated at the transcriptional
level [21,22]. In macrophages, LPS activates the tran-
scription factor nuclear factor-B (NF-B), which leads
to induction of expression of many immediate early
genes [23]. Exposure of cells to LPS causes rapid phos-
phorylation of inhibitor B (IB) by IB kinase (IKK),
with subsequent degradation by proteosomes. Dissocia-
tion of IB from NF-B allows the activated free dimer
to translocate to the nucleus [24], where it induces the
gene transcription through the cis-acting B element. The
NF-B activation is regulated by mitogen-activated pro-
tein kinases (MAPK) [25]. In fact, the extracellular sig-
nal-regulated kinases (ERK) 1/2 signalling pathway have
been often implicated in NF-B activation through phos-
phorylation and subsequent degradation of the inhibi-
tory subunit IB [26,27].
In this study, we have examined, in murine macrophages
J774 cell line stimulated with LPS, the eVects of anthocya-
nins present in a blackberry extract and cyanidin-3-O-glu-
coside on NO production, iNOS protein expression and
signal pathways involved in its regulation. To this aim, we
have utilised a blackberry extract, whose content in antho-
cyanins was mainly due (by about 88%) to cyanidin-3-O-
glucoside. Small amounts of other anthocyanins, some of
them only recently identiWed [28], were also present.
Experimental procedures
Anthocyanins contained in blackberry extract
Blackberry fruits were obtained as commercial products.
Fruit extract (43.6 g) was obtained by pounding in a mortar
about 1 kg of fruits. The extract was centrifuged at
6000 rpm for 20 min, the juice Wltered on glass wool, and the
pulps extracted overnight with about 1 L of ethyl alcohol
(EtOH)/HCl (99:1, v/v) at room temperature. The Wltered
extract was concentrated under reduced pressure and
diluted with water (1:1, v/v). Both the Wltered juice and the
pulp extract were applied to a C18 silica column previously
activated with 10 ml of EtOH and 10 ml of water. Anthocy-
anins were extracted with 1 L of EtOH/HCl (99:1, v/v) and
the solvent removed under reduced pressure. The anthocya-
nin fraction so obtained was used for chemical character-
isation [28] and in vitro studies. The anthocyanin content
was determined spectrophotometrically by absorbance at
518 nm and by HPLC analysis with photodiode arraydetector using a calibration curve obtained by analysing
diVerent concentrations of cyanidin-3-O-glucoside
(Extrasynthese) (Fig. 1A) standard (external standard
method). The curve was used to obtain quantitative data
for all the components of the anthocyanin fraction. This is
possible because anthocyanins present in blackberry extract
have similar spectroscopic properties and a comparable
molecular mass and consequently concentrations can
be correctly expressed in terms of cyanidin-3-O-glucoside,
available as pure standard. In HPLC analysis, the areas of
the Wve peaks were summed and measured against cyani-
din-3-O-glucoside curve (Fig. 1B). The extract contained
331 mg of anthocyanins expressed as cyanidin-3-O-gluco-
side. Cyanidin-3-O-glucoside was the main component of
the fraction (88.0%); pelargonidin-3-O-glucoside, cyanidin-
3-O-xyloside, malvidin-3-O-glucoside, and unknown
anthocyanins were also present at a level of 2.5, 7.1, 1.2, and
1.2% respectively. Values reported are the average of three
Fig. 1. (A) Structure of cyanidin-3-O-glucoside (as chloride). (B) HPLC-
UV and MS chromatograms, (see Experimental procedures), of anthocyanin
fraction of blackberry extract. 1. cyanidin-3-O-galactoside, 2. cyanidin-3-
O-glucoside, 3. cyanidin-3-O-arabinoside, 4. pelargonidin-3-O-glucoside,
5. cyanidin-3-O-xyloside, and 6. malvidin-3-O-glucoside.
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than 3.5% for both spectrophotometric and HPLC methods.
Cell culture
The murine monocyte/macrophage J774 cell line was
grown in Dulbecco’s modiWed Eagle’s medium (DMEM)
supplemented with 2 mM glutamine, 25 mM Hepes, penicil-
lin (100 U/ml), streptomycin (100g/ml), 10% foetal bovine
serum (FBS), and 1.2% Na pyruvate.
Cells were plated to a seeding density of in P60 well
plates and 2.5 £ 105 in 24 multiwell. Cells were pre-treated
(for 2 h) with increasing concentration of test compounds,
and stimulated with LPS from Escherichia coli, Serotype
0111:B4, (10g/ml). Treatment with test compounds and/or
LPS was carried out under serum-free conditions.
Cell viability
Cell respiration, an indicator of cell viability, was
assessed by the mitocondrial-dependent reduction of 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) to formazan [29]. After stimulation with LPS in the
absence or presence of anthocyanins of the blackberry
extract (11, 22, 45, and 90g/ml) for 24 h, cells were incu-
bated in 96-well plates with MTT (0.2 mg/ml), for 1 h. Cul-
ture medium was removed by aspiration and the cells were
solubilized in DMSO (0.1 ml). The extent of reduction of
MTT to formazan within cells was quantiWed by the mea-
surement of OD550.
Nitrite assay
Cells were pre-treated with test compounds for 2 h and
further incubated for 24 h with LPS (10g/ml). At the end
of the incubation, the supernatants were collected for the
nitrite measurement. The nitrite concentration in the sam-
ples was measured by the Griess reaction, by adding 100l
of Griess reagent (0.1% naphthylethylenediamide dihydro-
chloride in H2O and 1% sulphanilamide in 5% concentrated
H2PO4; vol. 1:1) to 100l samples. The optical density at
550 nm (OD550) was measured using ELISA microplate
reader (SLT-Labinstruments Salzburg, Austria). Nitrite
concentration was calculated by comparison with OD550 of
standard solutions of sodium nitrite prepared in culture
medium.
Animals
Male Wistar rats (Charles River), weighting 250–300 g,
were used after 1 week for adaptation to the housing condi-
tions. Rats were housed in a controlled environment and
provided with standard rodent chow and water. Animal
care was in compliance with Italian regulations (DM
116192) on protection of animals used for experimental and
other scientiWc purpose, as well as with the EEC regulations
(OJ of EC L 358/1 18/12/1986).Inducible NO synthase preparation
The inducible isoform of NO synthase was prepared
from lungs of rats treated with LPS (6 mg/kg, i.p.) or vehicle
(saline). Six hours after treatment, animals were anaesthe-
tized with urethane (1.3 g/Kg), the right ventricle was cann-
ulated and the lung, perfused through the pulmonary artery
for 2–3 min with 0.9% NaCl (5 ml/min, outXow via the pul-
monary vein), was explanted and frozen in liquid nitrogen.
Lungs were homogenized at 4 °C in 4 volumes of Hepes
buVer 20 mM, pH 7.2, containing 320 mM sucrose, 1 mM
DL-dithiothreitol, 10g/ml soybean trypsin inhibitor, 2g/
ml aprotinin, and 10g/ml leupeptin. The homogenate was
centrifuged at 100,000g (L8-70 ultracentrifuge, Beckman)
for 30 min at 4 °C. The supernatants, i.e., the cytosolic frac-
tions containing NO synthase activity, were stored at
¡80 °C until use. Protein concentration in the cytosolic
fraction was measured spectrophotometrically using the
Bio-Rad protein assay kit (Bio-Rad Laboratories) and
bovine serum albumin as standard.
Assay of NO synthase activity
NOS activity was evaluated by measuring the rate of
conversion of L-[U-14C]arginine to citrulline, according to
Salter [30]. BrieXy, an aliquot of the cytosolic fraction was
pre-incubated for 5 min at 37 °C in 50 mM potassium phos-
phate buVer, pH 7.2 in the presence or absence of anthocya-
nins of the blackberry extract (11, 22, 45, and 90g/ml).
Samples were then incubated for 10 min at 37 °C with L-[U-
14C]arginine (150,000 dpm, speciWc activity 313 mCi/mmol,
Perkin-Elmer Life Sciences) and 20M L-arginine (Sigma).
The reaction was stopped by the addition of 1.0 ml of a
mixture of H2O/Dowex-50W 1:1 v/v (Sigma). The Na
+-
form of Dowex-50W was prepared by washing four times
the H+-form of resin with 1 M NaOH and then with bi-dis-
tilled water until the pH was less than 7.5. The resin was set-
tled by centrifugation (11,000g for 3 min) in a microfuge
and an aliquot of the supernatant was taken for scintilla-
tion counting. The activity of inducible Ca2+/independent
enzyme was determined from the diVerence between the
labelled citrulline produced by samples containing 1 mM
EGTA and samples containing 1 mM EGTA plus 1 mM
NG-monomethyl-L-arginine (L-NMMA), a NOS inhibitor.
The activity was expressed as pmol/min/mg of protein.
Western blot analysis
The analysis of pERK-1/2, ERK-2, and iNOS in J774
macrophages was performed on whole cell lysates. After
stimulation with LPS for 15 min (pERK-1/2, ERK-2) or
24 h (iNOS), cells were washed with cold PBS and lysed for
10 min at 4 °C with lysis buVer (50 mM Tris, pH 7.4, 0.5%
Nonidet P-40, and 0.01% SDS) containing complete prote-
ase inhibitor cocktail (Roche Applied Science). Lysates
from adherent cells were collected by scraping and centri-
fuged at 12,000g for 15 min at 4 °C. The supernatants were
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determined by Bio-Rad Protein Assay (Bio-Rad). The anal-
ysis of IB was performed on cytosolic extract. Thirty
minutes after LPS stimulation, cells were washed with cold
PBS, harvested in cold hypotonic lysis buVer (10 mM
Hepes, 1.5 mM MgCl2, 10 mM KCl, 0.5 mM phenylethylsul-
phonylXuoride, 1.5g/ml soybean trypsin inhibitor, 7 g/ml
pepstatin A, 5g/ml leupeptin, 0.1 mM benzamidine, and
0.5 mM DTT) and incubated on ice for 15 min. The cells
were lysed by rapid passage through a syringe needle for
Wve times and the cytoplasmic fraction was then obtained
by centrifugation at 13,000g for 1 min at 4 °C. The superna-
tants were collected and protein concentration was deter-
mined.
Equal amounts of protein (50g) were mixed with gel
loading buVer (50 mM Tris, 10% SDS, 10% glycerol, 10% 2-
mercaptoethanol, and 2 mg/ml of bromophenol) in a ratio
of 1:1, boiled for 3 min and centrifuged at 10,000g for
10 min. Each sample was loaded and electrophoresed on a
10% SDS–polyacrylamide gel. The proteins were trans-
ferred on to nitrocellulose membranes (Hybond ECL
Nitrocellulose, Amersham). The membranes were blocked
with 0.1% PBS-Tween containing 5% non-fat dry milk for
ERK-2, IB, iNOS and -actin, whereas with 0.1% PBS-
Tween containing 5% non-fat dry milk and 50 mM NaF for
pERK-1/2. After the blocking, the membranes were incu-
bated with the relative primary antibody overnight at 4 °C.
Mouse monoclonal antibodies anti ERK-2, IB (Santa
Cruz Biotechnology) and anti iNOS (BD Transduction
Laboratories) were diluted 1:1000 in 0.1% PBS-Tween, 5%
non-fat dry milk; mouse monoclonal antibody anti pERK-
1/2 (Santa Cruz Biotechnology) was diluted 1:1000 in 0.1%
PBS-Tween, 5% non-fat dry milk, 50 mM NaF; mouse
monoclonal antibody anti -actin (Sigma–Aldrich) was
diluted 1:10000 in 0.1% PBS-Tween, 5% BSA. After the
incubation, the membranes were washed six times with
0.1% PBS-Tween and were incubated for 1.5 h at room tem-
perature with horseradish peroxidase-conjugated anti-
mouse secondary antibodies (Dako Cytomation) diluted
1:1000 in 0.1% PBS-Tween containing 5% non-fat dry milk.
The membranes were washed and protein bands were
detected by an enhanced chemiluminescence system (Amer-
sham Pharmacia). Densitometric analysis was performed
with a Fluor S quantitative imaging system (Bio-Rad Labo-
ratories).
Electrophoretic mobility shift assay
To analyze NF-B DNA binding activity, total cell
extracts were prepared by using a detergent lysis buVer
(50 mM Tris, pH 7.4, 150 mM NaCl, 50 mM NaF, 1 mM
Na3VO4, 0.5% Nonidet P-40, 0.5 mM dithiothreitol, and
complete protease inhibitors mixture (Roche Applied Sci-
ence)). After LPS stimulation, cells were harvested by cen-
trifugation at 4 °C for 10 min at 180g, washed on ice in cold
PBS, and resuspended in detergent lysis buVer (301/
5 £ 106 cells). The cell lysate was incubated on ice for 30 minand then centrifuged at 4 °C for 5 min at 10,000g. The pro-
tein content of the supernatant was determined, and equal
amounts of protein (10g) were added to a reaction mix-
ture containing 20g of bovine serum albumin, 2g of
poly(dI–dC), 10l of binding buVer (20 mM Hepes, pH 7.9,
10 mM MgCl2, 20% glycerol, 100 mM KCl, 0.2 mM EDTA,
0.5 mM dithiothreitol, and 0.5 mM phenylmethylsulfonyl-
Xuoride), and 150,000 dpm of a 32P-labeled consensus NF-
B binding oligonucleotide (Santa Cruz Biotechnology) in
a Wnal volume of 20l. The speciWcity of the DNA–protein
binding was determined by competition reactions in which
a 50-fold molar excess of unlabelled oligonucleotide was
added to the binding reaction. Samples were incubated at
room temperature for 30 min and run on a non-denaturing
4% polyacrylamide gel. Autoradiography was done for 18 h
on Kodak XAR 5 Wlm.
Statistical analysis
The results are expressed as means § standard error
(SEM) of the mean of n observations, where n represents
the number of experiments performed in diVerent days.
Triplicate wells were used for the various treatment condi-
tions. The results were analysed by one-way ANOVA fol-
lowed by a Bonferroni post hoc test for multiple
comparisons. A p-value less than 0.05 was considered sig-
niWcant.
Results
EVect of anthocyanin fraction of blackberry extract on 
LPS-induced nitrite production
To asses whether the anthocyanin fraction of the black-
berry extract was able to reduce NO production we utilized
the Griess assay to measure nitrite, the stable end-product
of NO, in supernatants of the murine macrophage cell line
J774 stimulated with LPS (10g/ml). A marked increase of
nitrite production in the cell medium was observed at 24 h
(23.10 § 0.55 nmol/106 cells; p < 0.001, n D 3) in respect to
unstimulated macrophages (3.12 § 0.40 nmol/106 cells).
When the anthocyanin fraction of the blackberry extract (0,
11, 22, 45, and 90g/ml) was added to J774 macrophages,
2 h before LPS stimulation, a signiWcant (p < 0.001, n D 3)
and concentration-dependent decrease of nitrite production
in cell medium was observed (Fig. 2A). In fact, the observed
inhibition was 23, 34, 60, and 70% at 11, 22, 45, and 90g/
ml respectively (p < 0.001, n D 3). The IC50 was 36g/ml
(95% IC 24–53g/ml; r2 0.976). The aminoguanidine (10g/
ml), a well known inhibitor of iNOS enzyme, inhibited the
nitrite production by 84% (p < 0.001, n D 3).
To exclude the possibility that the inhibitory eVect of the
anthocyanin fraction of the blackberry extract on LPS-
induced NO production was due to cytotoxicity, J774 cells,
stimulated for 24 h with LPS after pre-treatment with test
compound, were tested for cell viability using MTT assay.
No signiWcant diVerence was observed between the viability
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pound plus LPS, at any of the concentrations examined
(data not shown).
EVect of anthocyanin fraction of blackberry extract on iNOS 
catalytic activity
To evaluate the eVect of anthocyanin fraction of the
blackberry extract on inducible enzyme activity, we utilized
as a source of the enzyme the lung of LPS-treated rats. The
inducible NO synthase activity from lungs of LPS-treated
rats was 25.8 § 1.29 pmol/min/mg of protein (n D 3). No
activity was present in the lungs of vehicle treated rats. The
anthocyanin fraction of the blackberry extract (0, 11, 22, 45,
and 90g/ml) signiWcantly inhibited in a concentration-
Fig. 2. EVect of anthocyanin fraction of blackberry extract on LPS-
induced nitrite production (A) and iNOS activity (B). (A) J774 cells were
pre-treated for 2 h with test compound (0, 11, 22, 45, and 90 g/ml), prior
to LPS stimulation (10 g/ml) for 24 h. Aminoguanidine (AMG: 10 g/
ml), a known inhibitor of NOS enzyme, acted as a positive control.
Unstimulated J774 cells acted as a negative control (C). Nitrites, stable
end-products of NO, were measured by the Griess reaction. (B) iNOS
enzyme was prepared from lungs of LPS-treated rats (6 mg/kg, i.p) 6 h
after stimulation and iNOS activity was evaluated by measuring the rate
of conversion of L-[U-14C]arginine to [U-14C]citrulline (see Experimental
procedures). Data are expressed as means § SEM from three separate
experiments performed in triplicate. ***P < 0.001 vs unstimulated cells
(C), p < 0.001 vs LPS alone; *p < 0.05; #p < 0.001 vs iNOS activity (0 g/ml
anthocyanin fraction blackberry extract).
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Bdependent manner the activity of the enzyme (Fig. 2B). In
fact, the observed inhibition was 17 (p < 0.05; n D 3), 28, 40,
and 65% (p < 0.001, n D 3) at 11, 22, 45, and 90g/ml respec-
tively. The IC50 was 56g/ml (95% IC 37 to 84g/ml; r
2
0.977). The aminoguanidine (10 g/ml) inhibited the iNOS
catalytic activity by 83% (p < 0.001, n D 3).
EVect of anthocyanin fraction of blackberry extract on 
LPS-induced iNOS expression
To determine whether the inhibition of LPS-induced
nitrite production by test compound was mediated by the
regulation of iNOS protein expression, next we evaluated the
levels of iNOS protein in whole lysates from J774 cells stimu-
lated with LPS and pre-treated with test compound, as
described above. As shown in Fig. 3, LPS (10g/ml) caused,
at 24 h, a signiWcant increase of iNOS protein levels com-
pared to unstimulated cells (control). When cells were pre-
treated with the anthocyanin fraction (0, 11, 22, 45, and
90g/ml) for 2h before LPS stimulation, iNOS protein
expression was inhibited in concentration-dependent
manner in respect to LPS-stimulated cells, but only from the
concentration of 22g/ml (p < 0.001, nD3). In fact, the
observed inhibition was 13%, at the lowest concentration
Fig. 3. EVect of anthocyanin fraction of blackberry extract on LPS-
induced iNOS expression. J774 cells, pre-treated (for 2 h) with increasing
concentration of test compound (0, 11, 22, 45 and 90 g/ml), were stimu-
lated with LPS (10 g/ml) for 24 h. Equal amounts of whole lysates, con-
taining 50 g of proteins, were fractionated by 10% SDS–PAGE and
subjected to Western blot analysis using 1:1000 diluted iNOS antiserum.
iNOS protein was visualized by chemoluminescence Western blotting
detection reagents. The bands corresponding to iNOS protein were quan-
tiWed by densitometric analysis and the results are expressed as a percent-
age of LPS-stimulated cells. Densitometric analysis of iNOS protein
expression represents the mean § SEM from three separate experiments.
Data were normalized on the basis of -actin levels. p < 0.001 vs LPS
alone.
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C. Pergola et al. / Nitric Oxide 15 (2006) 30–39 35tested (11g/ml, p >0.05, nD3), 53, 78, and 94.5% at 22, 45,
and 90g/ml, respectively (p < 0.001, nD3) (Fig. 3). Test com-
pound given alone to J774 cells did not inXuence iNOS pro-
tein expression in respect to control cells (data not shown).
EVect of anthocyanin fraction of blackberry extract on 
NF-B activation
Because activation of NF-B is critical for the induction
of iNOS by LPS, we determined whether the anthocyanin
fraction of the blackberry extract might suppress NF-B
activation in LPS-activated macrophages. To this aim, we
performed an electrophoretic mobility shift assay (EMSA)
on extract from J774 pre-treated (2 h before LPS) with the
highest concentration (90g/ml) of test compound. LPS
treatment caused nuclear translocation of NF-B and
induced its DNA binding activity in a time dependent
manner, which peaked between 0.5 and 1 h (data not
shown). As shown in Fig. 4A, the induction of speciWc NF-
B binding activity by LPS was reduced by anthocyanin
fraction of the blackberry extract. The speciWcity of the
protein-DNA complex was conWrmed by a competition
assay. Binding was competed by the addition of non-radio-
active B oligonucleotide. Since it has been well docu-
mented that activation of NF-B correlates with rapid
proteolytic degradation of IB, the levels of this protein
were investigated as an index of NF-B inhibition by test
compound. As shown in Fig. 4B, following cell stimulation
with LPS for 30 min, a degradation of IB was observed,
whereas pre-treatment (2 h before LPS) with test com-
pound (0, 11, 22, 45, and 90 g/ml) prevented IB degra-
dation in a concentration-dependent manner, but only
from the concentration of 22g/ml (p < 0.001, n D 3). In
fact, the observed inhibition of IB degradation was 11%,
at the lowest concentration tested (11g/ml, p > 0.05,
n D 3), 48, 65, and 83% at 22, 45, and 90g/ml, respectively
(p < 0.001, n D 3).
EVect of anthocyanin fraction of blackberry extract on 
LPS-induced ERK-1/2 activation
To investigate whether the inhibition of iNOS expres-
sion and IB degradation, observed in our experimental
conditions, corresponded to a modulation of MAPK path-
way, one of the signal transduction pathways involved in
the regulation of iNOS expression, we analysed ERK-1/2
activation 15 min after LPS treatment, in the presence or
absence of anthocyanins of the blackberry extract (2 h
before LPS). In fact ERK signalling pathway has been
often implicated in NF-B activation through phosphory-
lation and subsequent degradation of the inhibitory sub-
unit IB [26,27]. As shown in Fig. 5, stimulation of the
cells in the presence of LPS-induced ERK-1/2 phosphoryla-
tion. In the presence of increasing concentrations of the
anthocyanin fraction of the blackberry extract (0, 11, 22, 45,
and 90g/ml) a concentration-dependent and signiWcant
inhibition of ERK-1/2 phosphorylation was observed, butonly from the concentration of 22g/ml (71%, p < 0.001,
n D 3). At 45 and 90g/ml the observed inhibition was 79
and 83%, respectively (p < 0.001, n D 3).
EVect of cyanidin-3-O-glucoside on LPS-induced iNOS 
expression, IB degradation and ERK-1/2 activation
Since cyanidin-3-O-glucoside accounted for the 88% of
the anthocyanin fraction of the blackberry extract uti-
lized, we investigated the eVect of this anthocyanin on
LPS-induced iNOS expression in J774 cells. Similarly to
what observed with the extract, pre-treatment of the LPS-
stimulated cells with increasing concentrations of the
Fig. 4. EVect of anthocyanin fraction of blackberry extract on NF-B acti-
vation (A) J774 cells, pre-treated (for 2 h) with test compound at the con-
centration of 90 g/ml, were stimulated with LPS (10 g/ml) for 30 min.
EMSA was performed on total cell lysates containing 10 g of proteins in
the presence of a 32P-labeled NF-B oligonucleotide alone or with a 50-
fold molar excess of analogous unlabeled oligonucleotide as competitor.
Results are representative of three independent experiments. (B) J774
cells, pre-treated (for 2 h) with increasing concentration of test compound
(0, 11, 22, 45, and 90 g/ml), were stimulated with LPS (10 g/ml) for
30 min. Equal amounts of cytosolic extract, containing 50 g of proteins,
were fractionated by 10% SDS–PAGE and subjected to Western blot
analysis using 1:1000 diluted IB antiserum. IB protein was visualized
by chemoluminescence Western blotting detection reagents. The bands
corresponding to IB were quantiWed by densitometric analysis and the
results are expressed as a percentage of LPS-induced degradation. Densi-
tometric analysis of IB protein expression represents the mean § SEM
from three separate experiments. Data were normalized on the basis of -
actin levels. p < 0.001 vs LPS alone.
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amounts corresponding to the concentrations present in
the blackberry extract) inhibited iNOS expression in a
concentration-dependent manner (p < 0.001, n D 3), but
only from the concentration of 20 g/ml (Fig. 6A). In fact,
the observed inhibition was 23% at 10 g/ml (p > 0.05,
n D 3), the lowest concentration tested, 69, 81, and 99% at
20, 40, and 80 g/ml, respectively (p < 0.001, n D 3). More-
over, similarly to what observed with the blackberry
extract, cyanidin-3-O-glucoside (0, 10, 20, 40, and 80 g/
ml) prevented IB degradation and inhibited ERK-1/2
phosphorylation in a concentration-dependent manner
(p < 0.001, n D 3), but only from the concentration of
20 g/ml (44 and 48%, respectively). At the highest con-
centrations utilized the inhibition of IB degradation
was 62% at 40 g/ml and 80% at 80 g/ml (Fig. 6B;
p < 0.001, n D 3), whereas the inhibition of ERK-1/2 acti-
vation was 70% at 40 g/ml and 74% at 80 g/ml (Fig. 6C;
p < 0.001, n D 3).
Discussion
Recently, much attention has focused on the protective
function of naturally occurring antioxidants in biological
systems, and on the mechanisms of their action. Phenolic
Fig. 5. EVect of anthocyanin fraction of blackberry extract on LPS-
induced ERK-1/2 activation J774 cells, pre-treated (for 2 h) with increas-
ing concentration of test compound (0, 11, 22, 45, and 90 g/ml), were
stimulated with LPS (10 g/ml) for 15 min. Equal amounts of lysates con-
taining 50 g of proteins were fractionated by 10% SDS–PAGE and sub-
jected to Western blot analysis using 1:1000 diluted pERK-1/2 antiserum.
pERK-1/2 protein was visualized by chemoluminescence Western blotting
detection reagents. The bands corresponding to pERK-1/2 protein were
quantiWed by densitometric analysis and the results are expressed as a per-
centage of LPS-stimulated cells. Densitometric analysis of pERK-1/2 pro-
tein expression represents the mean § SEM from three separate
experiments. Data were normalized on the basis of ERK-2 levels.
p < 0.001 vs LPS alone.Fig. 6. EVect of cyanidin-3-O-glucoside on LPS-induced iNOS expression
(A), IkB degradation (B), and ERK-1/2 activation (C). J774 cells, pre-
treated (for 2 h) with increasing concentration of cyanidin-3-O-glucoside
(0, 10, 20, 40, and 80 g/ml, amounts corresponding to the concentrations
present in the blackberry extract), were stimulated with LPS (10 g/ml) for
24 h (iNOS), 30 min (IB) and 15 min (pERK-1/2). Cell lysates and west-
ern blot analysis were performed as described (see Experimental proce-
dures). The bands were quantiWed by densitometric analysis and the
results are expressed as a percentage of LPS-stimulated cells (iNOS,
pERK-1/2) and as a percentage of LPS-induced degradation (IB). Den-
sitometric analysis of protein expression represents the mean § SEM from
three separate experiments. Data were normalized on the basis of -actin
(iNOS, IB) and ERK-2 (pERK-1/2) levels. p < 0.001 vs LPS alone.
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sidered to play an important role as dietary antioxidants
for the prevention of oxidative damage caused, in living
systems, by active oxygen radicals.
Anthocyanin pigments are widely distributed in the
human diet through crops, beans, fruits, and vegetables,
suggesting that we ingest considerable amounts of anthocy-
anin pigments from plant based daily diets. The protective
role and safety suggest that they can be used as drugs for
some oxidative-damage-induced diseases. Moreover, sev-
eral Xavonoids are biochemically active compounds with
known anti-inXammatory, anticarcinogenic, and free radi-
cal scavenging properties. In fact in previous studies, we
have demonstrated that anthocyanins from blackberry
extract reduce acute lung inXammation [31], circulatory
failure and multiple organ dysfunction caused by endo-
toxin in the rat [6]. Several studies have demonstrated that
anthocyanins protect against endothelial dysfunction and
inhibit endothelial cell apoptosis [11,13,32]. In this regard
the extract utilized in this study has been shown to exert
antioxidant activity through the inhibition of the peroxyni-
trite-induced oxidative damage of the endothelium [12].
Moreover, some studies have reported that dietary antho-
cyanins, such as cyanidin-3-O-glucoside, are directly
absorbed in rats and humans, appear in the blood, and are
excreted intact in urine [33,34], suggesting that the gluco-
side form of cyanidin is important.
During infection and inXammation, high production of
NO has been shown to cause DNA damage as well as
mutations in vivo [35]. The formation of carcinogenic N-
nitrosamines, resulting from elevated NO formation, has
been also demonstrated in cell cultures and in vivo [36].
Recently, it has been suggested that iNOS over-expression
may be intimately involved in the pathogenesis of many
diseases, such as colon cancer, multiple sclerosis, neurode-
generative diseases, and heart infarction. The inducible
NOS derived from macrophages is predominantly responsi-
ble for the overproduction of NO in injured tissues and
inXammation processes [37]. Thus, we have performed our
studies in murine macrophage cell line J774, which express
iNOS, following stimulation with LPS.
We utilized a blackberry extract whose content in antho-
cyanins was mainly due (by about 88%) to cyanidin-3-O-
glucoside and we compared its anti-inXammatory activity
to the one obtained with cyanidin-3-O-glucoside standard.
First of all, our results demonstrate that the anti-inXamma-
tory activity of the anthocyanin fraction of the blackberry
extract is mainly due to the cyanidin-3-O-glucoside, since
all the parameters tested were inhibited to the same extent
by both anthocyanin fraction and cyanidin-3-O-glucoside.
Moreover, we suggest a molecular basis for this anti-
inXammatory eVect.
Our results demonstrate that LPS-induced NO produc-
tion in J774 cells is susceptible to inhibition by blackberry
extract through dual mechanism, since it attenuated iNOS
protein expression and concomitantly decreased iNOS
activity. Moreover, a direct inhibition of iNOS activity inlungs from LPS-stimulated rats was observed in agreement
with our previously published data [6], although the mecha-
nism of this action has not been investigated.
The action of cyanidin-3-O-glucoside on NO production
has been particularly studied with regard to eNOS. In fact
it has been demonstrated that, in bovine vascular endothe-
lial cells, the compound induces eNOS expression and NO
production [38] and increases vascular eNOS activity [39].
Thus, cyanidin-3-O-glucoside seems to display opposite
eVects on diVerent isoforms of NOS, since in our study it
exerts an inhibitory activity on iNOS. This could be due to
diVerent roles exerted by the two isoforms in diVerent path-
ophysiological contest. In fact, it must be considered that
while the generation of NO by eNOS plays a major role in
maintaining cardiovascular homeostasis, on the contrary
the chronic production of NO by iNOS, such as in heart
failure and ischemia-reperfusion, exerts deleterious eVects
on circulatory function [40,41]. Similarly to cyanidin-3-O-
glucoside, other polyphenolic compounds have been shown
to exert, in diVerent experimental models [42], opposite
eVects on NO production: an increase in NO production
via eNOS and an inhibition of NO production via iNOS
enzyme. Thus, the Xavonoids may contribute to the balance
between iNOS and eNOS in diVerent pathophysiological
systems.
NO produced by iNOS in J774 macrophages is regulated
at the transcriptional level, predominantly via NF-B-med-
iated pathway. It is interesting to note that NF-B is
involved in the induction of iNOS also in humans [43,44].
Our results demonstrate that anthocyanin fraction of the
blackberry extract, and similarly cyanidin-3-O-glucoside,
decreases iNOS protein by inhibition of LPS-induced NF-
B activation.
Accumulating evidence indicates that NF-B activation,
which is essential for gene transcription regulation, is mod-
ulated by MAPK/ERK kinase kinase-1 (MEKK-1). In fact,
the activation of ERK-1 and -2 has been shown to be
involved, in murine macrophages [45], in stimulation of
NF-B activity and iNOS expression through phosphoryla-
tion and subsequent degradation of the inhibitory subunit
IB [25]. Moreover, it has been demonstrated, in mouse
macrophages and in human colon epithelial cells [46], that
the inhibition of ERK-1/2 directly suppresses endotoxin-
induced NO synthesis. Our results demonstrate that antho-
cyanin fraction of the blackberry extract, and particularly
the major anthocyanin present in the extract, cyanidin-3-O-
glucoside, inhibited in a concentration-dependent manner
both IB degradation and ERK-1/2 activation. Thus
blackberry extract and cyanidin-3-O-glucoside could
inhibit iNOS expression by attenuating IB degradation
via ERK-1/2 or by inhibiting directly ERK-1/2 activation
or by both mechanisms.
In conclusion, our study demonstrates that at least some
part of the anti-inXammatory activity of the anthocyanin
fraction of blackberry extract is due to suppression of NO
production by cyanidin-3-O-glucoside, which is the main
anthocyanin present in the extract. The mechanism of this
38 C. Pergola et al. / Nitric Oxide 15 (2006) 30–39inhibition seems to be due to an action on the expression/
activity of the enzyme. In particular, protein expression was
inhibited through the attenuation of NF-B and/or MAPK
activation.
Thus, since up-regulation of iNOS has been associated
with pathophysiology of certain types of human cancer as
well as inXammatory disorders, our results suggest that
anthocyanins of blackberry extract, and particularly cyani-
din-3-O-glucoside, could exert beneWcial action as iNOS
inhibitors. Moreover, additional important therapeutic
implications are suggested by the modulation of NF-B, an
ubiquitous transcription factor which controls the gene
expression of numerous enzymes, cytokines, cell adhesion
molecules, and growth factors involved in inXammation,
carcinogenesis, and other immunological disorders. More
generally since NF-B and iNOS are deeply involved in the
inXammatory process our Wndings, together with the
reported antioxidant activity as peroxynitrite scavenger [12]
and according to others [47], could suggest that anthocya-
nin dietary daily intake might have beneWcial implications
in the prevention of inXammatory diseases.
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